CAAS Capital Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,125
Closed -$883K 1056
2021
Q1
$883K Buy
+4,125
New +$883K 0.01% 457
2020
Q4
Sell
-1,637
Closed -$173K 663
2020
Q3
$173K Sell
1,637
-4,613
-74% -$488K ﹤0.01% 253
2020
Q2
$613K Buy
+6,250
New +$613K 0.02% 136